• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Stock Price









Similar threads

Replies
380
Views
50K
Replies
36
Views
4K
Pfizer
anonymous
Replies
8
Views
2K
Pfizer
anonymous
Replies
5
Views
2K
Pfizer
anonymous
Replies
13
Views
2K
Pfizer
Anonymous